Kexing Biopharm Logo

Kexing Biopharm

Develops and produces recombinant protein drugs and micro-ecological preparations.

688136 | Shanghai Stock Exchange

Overview

Corporate Details

ISIN(s):
CNE100006ZG6
LEI:
529900Z34Q1M9A907771
Country:
China
Address:
N/A

Description

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-01 21:05
Kexing Biopharm prasentiert globale Strategie und Kooperationsmoglichkeiten auf…
German 6.4 KB

Automate Your Workflow. Get a real-time feed of all Kexing Biopharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kexing Biopharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kexing Biopharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Esperion Therapeutics, Inc. Logo
Develops and commercializes oral medicines to reduce cardiovascular risk.
United States of America
ESPR
ESSA Pharma Inc. Logo
Develops drugs targeting the androgen receptor's N-terminal domain for prostate cancer.
United States of America
EPIX
Estrella Immunopharma, Inc. Logo
Clinical-stage biopharma developing T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ESLA
Eton Pharmaceuticals, Inc. Logo
Pharmaceutical company developing and commercializing treatments for rare diseases.
United States of America
ETON
EuBiologics Co., Ltd. Logo
A biopharmaceutical company developing vaccines and offering CRMO services.
South Korea
206650
EUPRAXIA PHARMACEUTICALS INC. Logo
Clinical-stage biotech developing locally delivered, extended-release therapies.
United States of America
EPRX
eureKING Logo
A SPAC created to acquire European biomanufacturing companies.
France
KINGS
EuroAPI Logo
Develops and manufactures APIs and provides CDMO services for complex molecules.
France
EAPI
Eurobio Scientific Logo
Specializes in in vitro diagnostics for transplantation, oncology, and infectious diseases.
France
ALERS
European Institute of Science AB Logo
Develops and sells diagnostic solutions and instruments for veterinary health.
Sweden
EURI B

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.